A pooled analysis of suicidality in double-blind, placebo-controlled studies of sertraline in adults

Journal of Clinical Psychiatry

Volumn 70, Issue 5, 2009, Pages 674-683

  Vanderburg, Douglas G ^a   Batzar, Evan ^a   Fogel, Ilan ^a   Kremer, Charlotte M E ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SERTRALINE;

ALCOHOLISM; ARTICLE; ATYPICAL DEPRESSION; BIPOLAR DISORDER; BULIMIA; CLINICAL TRIAL; COCAINE DEPENDENCE; DISEASE CLASSIFICATION; DISEASE DURATION; DYSPEPSIA; DYSTHYMIA; FIBROMYALGIA; FOOD AND DRUG ADMINISTRATION; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NEURASTHENIA; OBESITY; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SEXUAL FUNCTION; SMOKING CESSATION; SOCIAL PHOBIA; SUICIDAL IDEATION; TREATMENT DURATION;

ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; LIFE CHANGE EVENTS; MALE; PREVALENCE; SERTRALINE; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 67049164153     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.07m04004     Document Type: Article

References (46)

1. Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry 1970;117:437-438
2. Friedman S, Smith L, Fogel A. Suicidality in panic disorder: a comparison with schizophrenic, depressed, and other anxiety disorder outpatients. J Anxiety Disord 1999;13:447-461 (Pubitemid 29502201)
3. Vuorilehto MS, Melartin TK, Isometsa ET. Suicidal behaviour among primary-care patients with depressive disorders. Psychol Med 2006;36:203-210 (Pubitemid 43126144)
4. Tarrier N, Gregg L. Suicide risk in civilian PTSD patients: predictors of suicidal ideation, planning and attempts. Soc Psychiatry Psychiatr Epidemiol 2004;39:655-661 (Pubitemid 39369166)
5. Wittchen H-U, Kessler RC, Beesdo K, et al. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002;63(suppl 8):24-34 (Pubitemid 34535254)
6. Statham DJ, Heath AC, Madden PA, et al. Suicidal behaviour: an epidemiological and genetic study. Psychol Med 1998;28:839-855 (Pubitemid 28393563)
7. Pompili M, Amador XF, Girardi P, et al. Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry 2007;16:10 (Pubitemid 46534768)
8. Dutta R, Boydell J, Kennedy N, et al. Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychol Med 2007;37:839-847 (Pubitemid 46746328)
9. Laughren TP. FDA Briefing Document. FDA Web site. Available at: http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf. Accessed March 26, 2009
10. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147:207-210 (Pubitemid 20060476)
11. Stone MB, Jones ML. Clinical review: relationship between antidepressant drugs and suicidality in adults. FDA Web site. Available at: http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf. Accessed March 26, 2009
12. Hammad TA: Clinical Data Review. FDA Web site. Available at: http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads- Review.pdf. 2004. Accessed November 20, 2007
13. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-339 (Pubitemid 43345358)
14. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003;160:790-792 (Pubitemid 41079617)
15. Storosum JG, van Zwieten BJ, van den Brink W, et al. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 2001;158:1271-1275 (Pubitemid 32717702)
16. Hammad T, Laughren T, Racoosin JA. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacology 2006;26:203-207 (Pubitemid 43740348)
17. Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systemic review of randomized controlled trials. BMJ 2005;330:396-399 (Pubitemid 40288826)
18. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005;19:330-385 (Pubitemid 40288822)
19. Martinez C, Rietbrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and nonfatal self harm in first episode depression: nested case-control study. BMJ 2005;330:389-393 (Pubitemid 40288823)
20. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007;164:1035-1043 (Pubitemid 47121392)
21. Laughren TP. Current FDA View of Suicidality Data for Adult Antidepressant Trials. FDA Web site. Available at: http://www.fda.gov/ohrms/ dockets/ac/06/slides/2006-4272s1-00-index.htm. Accessed March 26, 2009
22. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985;41:55-68
23. Levenson M, Holland, C. Statistical Evaluation of Suicidality in Adults Treated with Antidepressants. FDA Web site. Available at:http://www.fda.gov/ ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf. Accessed March 26, 2009
24. March JS, Klee B, Kremer CME. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. J Child Adolesc Psychopharmacol 2006;16:91-102
25. Gibbons RD, Brown CH, Hur K, et al. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry 2007;164:1044-1049 (Pubitemid 47121393)
26. Klein DF. The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children. Neuropsychopharmacology 2006;31:689-699
27. Möller HJ. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? a systematic review. Eur Arch Psychiatry Clin Neurosci 2006;256:476-496 (Pubitemid 46020522)
28. Brent D. Antidepressants and suicidal behavior: cause or cure? Am J Psychiatry 2007;164:989-991
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
30. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389 (Pubitemid 9136500)
31. Acharya N, Rosen AS, Polzer JP, et al. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol 2006;26:587-594 (Pubitemid 44772735)
32. Pedersen AG. Citalopram and suicidality in adult major depression and anxiety disorders. Nord J Psychiatry 2006;60:392-399 (Pubitemid 44575518)
33. Perlis RH, Beasley CM Jr, Wines JD Jr, et al. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. Psychother Psychosom 2007;76:40-46 (Pubitemid 46005718)
34. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. Am J Psychiatry 2006;163:41-47
35. Libby AM, Brent DA, Morrato EH, et al. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007;164:884-891 (Pubitemid 46972903)
36. Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164:1356-1363 (Pubitemid 47461135)
37. Nemeroff CB, Kalali A, Keller MB, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 2007;64:466-472 (Pubitemid 46556464)
38. Leon AC. The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses. Am J Psychiatry 2007;164:1786-1789 (Pubitemid 351739229)
39. Leon AC, Marzuk PM, Tardiff K, et al. Antidepressants in adult suicides in New York City: 2001-2004. J Clin Psychiatry 2007;68:1399-1403
40. Olfson M, Marcus SC. A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J Clin Psychiatry 2008;69:425-432 (Pubitemid 351549396)
41. Olfson M, Marcus SC, Druss BG. Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry 2008;65:94-101
42. Olfson M, Shaffer D. SSRI prescriptions and the rate of suicide [letter with reply]. Am J Psychiatry 2007;164:1907-1910
43. Beasley CM Jr, Ball SG, Nilsson ME, et al. Fluoxetine and adult suicidality revisited: an updated meta-analysis using expanded data sources from placebo-controlled trials. J Clin Psychopharmacol 2007;27:682-686 (Pubitemid 351339457)
44. Tauscher-Wisniewski S, Disch D, Plewes J, et al. Evaluating suiciderelated adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder. Psychol Med 2007;37:1585-1593. Epub 2007 July 20 (Pubitemid 47606853)
45. Thompson TR, Dudle{êTK, Nanry KP. Analysis of suicidal ideation and behavior in lamotrigine clinical trials [poster]. Presented at the 48th annual New Clinical Drug Evaluation Unit meeting; May 27-29, 2008; Phoenix, Ariz
46. Posner K, Melvin GA, Stanley B, et al. Factors in the assessment of suicidality in youth. CNS Spectr 2007;12(2):156-162 (Pubitemid 46303280)